Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Acq. announced
CC transcript
Danimer Scientific, Inc. (LOAK.U) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/08/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/08/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/08/2023 8-K Quarterly results
Docs: "Danimer Scientific Announces Second Quarter 2023 Results -- Issues Separate Release Announcing Accepted Part 2 Application for DoE Loan Guarantee -- -- Expands Portfolio with Resins for Protective Films, Shrink Wrap & Produce Bags -- BAINBRIDGE, GA – August 8, 2023 – Danimer Scientific, Inc. , a leading next-generation bioplastics company focused on the development and production of highly engineered biodegradable materials, today announced financial results for its second quarter, ended June 30, 2023. Danimer announced, in a separate release also issued after the close of market today, the acceptance of its Part II Application by the U.S. Department of Energy under the Title XVII Loan Guarantee. The Company has been invited into the confirmatory due diligence and term sheet negotiation pr...",
"Second Quarter 2023 Earnings Presentation August 8, 2023"
06/05/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
06/05/2023 8-K Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits  Interactive Data
05/17/2023 144 Form 144 - Report of proposed sale of securities:
05/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
04/17/2023 144 Form 144 - Report of proposed sale of securities:
04/17/2023 ARS Form ARS - Annual Report to Security Holders:
04/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/28/2023 10-K Annual Report for the period ended December 31, 2022
03/28/2023 8-K Quarterly results
03/20/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/20/2023 8-K Quarterly results
03/10/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
03/07/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE IN RE DANIMER SCIENTIFIC, INC. ) ) c.a. no. 2023-____-___ verified petition for relief pursuant to 8 del. c. § 205 Petitioner Danimer Scientific, Inc. , by and through its undersigned counsel, brings this petition pursuant to 8 Del. C. § 205, seeking to have this Court validate a potentially defective corporate act as follows: nature of the action 1. The Company petitions this Court seeking relief similar to that several other public entities have recently sought from this Court. In particular, the Company seeks to validate its Fourth Amended and Restated Certificate of Incorporation of the Company adopted in connection with its business combination with Live Oak Acquisition Corp. in December 2020, which, among other things, increased the a..."
02/09/2023 5 CROSKREY STEPHEN (CEO & Chairman of the Board) has filed a Form 5 on Danimer Scientific, Inc.
02/09/2023 SC 13G/A VANGUARD GROUP INC reports a 4.9% stake in Danimer Scientific Inc.
02/01/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
11/08/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
11/08/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/08/2022 8-K Quarterly results
09/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
09/07/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
09/07/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/07/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "Danimer Scientific, Inc. $100,000,000 Class A Common Stock Equity Distribution Agreement",
"OPINION OF KANE KESSLER, P.C"
08/25/2022 S-3 Form S-3 - Registration statement under Securities Act of 1933:
08/15/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/15/2022 8-K Quarterly results
08/09/2022 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
Docs: "Danimer Scientific Announces Second Quarter 2022 Results BAINBRIDGE, GA – August 9, 2022 – Danimer Scientific, Inc. , a leading next generation bioplastics company focused on the development and production of biodegradable materials, announced today its financial results for the second quarter ended June 30, 2022. Stephen E. Croskrey, Chairman and Chief Executive Officer of Danimer commented, “Our customer conversations and business development efforts are moving forward. Our leadership position in research and development for PHA-based resins is strengthening our existing relationships while also creating new interest in our best-in-class biodegradable offerings. In June, we successfully started commissioning Phase II of our Kentucky Facility, which is performing better than our in...",
"2 3 4 5 6"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy